🇺🇸 FDA

Company profile · Sponsor

Orion

E091E17 · EMA pharma DOUAI, FR
Pipeline
8
Drugs
0
Patents
0

Quick answer

Orion (E091E17) is a pharma company. headquartered in DOUAI, FR. listed on EMA. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E091E17
Exchange EMA
Company type pharma
Headquarters DOUAI, FR

Pipeline (8)

Search pipeline →

  1. Arazasetron besylate

    Orion

    Cisplatine induced hearing loss

    phase 2 small molecule active

    1 trial

  2. MIDAZOLAM , ODM-208 100 mg Tablet, ODM-208 50 mg Tablet, ODM-208 25 mg Tablet, ODM-208 5 mg film-coated tablet

    Orion

    Metastatic castration-resistant prostate cancer.

    phase 2 small molecule active

    1 trial

  3. ODM-111 Placebo, Para-Tabs 500 mg tabletti, ODM-111, ODM-111

    Orion

    Chronic Pain due to Ostheoarthritis of the knee

    phase 2 small molecule active

    1 trial

  4. PACLITAXEL ALBUMIN-BOUND, NIVOLUMAB, GEMCITABINE, IPILIMUMAB, SOTORASIB, ODM-212 5 mg coated tablet, ODM-212 40 mg coated tablet

    Orion

    Neoplasms benign malignant and unspecified (incl. cysts and polyps)

    phase 2 small molecule active

    1 trial

  5. Para-Tabs 500 mg tabletti, ODM-111 Placebo, ODM-111, ODM-111

    Orion

    CHRONIC PAIN DUE TO DIABETIC PERIPHERAL NEUROPATHY

    phase 2 small molecule active

    1 trial

  6. Bioequivalence study 1 to compare pharmacokinetics of Parkinson´s disease drugs in healthy volunteers

    Orion

    Parkinson disease

    phase 1 other active

    1 trial

  7. Bioequivalence study 2 to compare pharmacokinetics of Parkinson´s disease drugs in healthy volunteers

    Orion

    Parkinson desease

    phase 1 other active

    1 trial

  8. Bioequivalence study comparing two temazepam 20 mg tablet formulations after fasted administration; an open, randomized, single centre, single dose study with crossover design in healthy subjects

    Orion

    short-term treatment of insomnia

    phase 1 other active

    1 trial

Frequently asked questions

What is Orion?

Orion (E091E17) is a pharma company. headquartered in DOUAI, FR. listed on EMA. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Orion sponsor?

We track 8 ClinicalTrials.gov-linked programs for Orion, including Arazasetron besylate and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Orion company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.